Gut Microbiota in Movement Disorders

The gut microbiota has been implicated in neurodevelopment, neuroinflammatory responses, and neurological disorders. Here is the latest research on the role of the gut microbiota in movement disorders.

January 16, 2022

Impact of intestinal disorders on central and peripheral nervous system diseases.

Neurobiology of Disease
Yumna El-HakimFarida Sohrabji
January 13, 2022

Effect of Coffee against MPTP-Induced Motor Deficits and Neurodegeneration in Mice Via Regulating Gut Microbiota.

Journal of Agricultural and Food Chemistry
Jiaming LiuYang Zhang
January 11, 2022
Open Access

Gut Microbiota and Acute Central Nervous System Injury: A New Target for Therapeutic Intervention.

Frontiers in Immunology
Bin YuanQi Wu
January 8, 2022

The Pivotal Role of Microbiota in Modulating the Neuronal-Glial-Epithelial Unit.

Infection and Drug Resistance
Siyu LuoDong Wan
January 6, 2022

A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.

Clinical Microbiology Reviews
Shokufeh Ghasemian SorboniSaman Soleimanpour
January 5, 2022

Challenges of repurposing tetracyclines for the treatment of Alzheimer's and Parkinson's disease.

Journal of Neural Transmission
Iva MarkulinMelita Salković-Petrisic
January 4, 2022
Open Access

Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease.

International Journal of Pharmaceutics: X
Jonas GhyselinckSimon Gaisford
January 3, 2022

Gut microbiota modulation by prednisolone in a rat kindling model of pentylenetetrazol (PTZ)-induced seizure.

Microbial Pathogenesis
Amanda Muliterno Domingues Lourenço de LimaSueli Teresinha Van Der Sand
December 27, 2021

Altered gut microbiota in Parkinson's disease patients with motor complications.

Parkinsonism & Related Disorders
Kai TakahashiTetsuya Maeda
December 25, 2021

Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease.

Trends in Endocrinology and Metabolism : TEM
Ehraz AnisPatrik Brundin
December 25, 2021
Open Access

Human Gut Microbiota in Health and Selected Cancers.

International Journal of Molecular Sciences
Aleksandra Sędzikowska, Leszek Szablewski
December 24, 2021

The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review.

Carmen BarrioIsabel Martín-Monzón
December 23, 2021

Is the Gut Microbiota a Neglected Aspect of Gut and Brain Disorders?

Yuvaraj BalanRaja Sundaramurthy
December 18, 2021

Remote Photobiomodulation Treatment for the Clinical Signs of Parkinson's Disease: A Case Series Conducted During COVID-19.

Photobiomodulation, Photomedicine, and Laser Surgery
Ann LiebertJohn Mitrofanis

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Adipose Tissue Heterogeneity

Examining the genomics, transcriptomics, proteomics, and metabolomics of adipose tissue at the single cell level will help build a single cell atlas of these tissues, providing insights into how changes in the map underlie health and disease states. Discover the latest research on adipose tissue heterogeneity here.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2022 Meta ULC. All rights reserved